AbbVie has agreed to buy Apogee Therapeutics for about $10.9 billion in cash in a deal that bolsters the biopharmaceutical company’s immunology and inflammation portfolio.
Source link
AbbVie to Buy Apogee Therapeutics for $10.9 Billion in Cash
Date:
More like thisRelated
Chris Young Safe After Scary Plane Incident
Chris Young experienced a terrifying close call while he was...
2026 NFL offseason: Biggest surprise players on each team
NFL NationJun 22, 2026, 06:00 AM ETCloseNFL Nation is...
Keir Starmer went from election landslide to downfall after his supporters deserted him
LONDON -- Dutiful rather than dynamic, Keir Starmer was...